Pharmacological Intervention to Modulate HDL: What Do We Target?

Overview of attention for article published in Frontiers in Pharmacology, January 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 85 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 37,760 followers.

@fvrmix @The_Nutrivore I've just been looking at HDL for a few hours, so here you go https://t.co/ZFR62ke6xs https://t.co/GxaCVjME5O https://t.co/5mfA7bCoXk https://t.co/GJO65fOnXe https://t.co/vW50JisA0d

02 Nov 2021

Reply Repost Favourite

@patentbobm @AviBittMD Sounds similar to the CETP inhibitors, which also had worse outcomes... "CETP reduce circulating HDL-C levels by transferring cholesteryl ester from HDL to larger lipoproteins... in exchange for triglyceride." https://t.co/A5BpLh9

25 Feb 2020

Reply Repost Favourite

RT @FrontPharmacol: Pharmacological Intervention to Modulate HDL: What Do We Target? https://t.co/usl9AHQnFb

23 Jan 2018

Reply Repost Favourite

Pharmacological Intervention to Modulate HDL: What Do We Target? https://t.co/usl9AHQnFb

23 Jan 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.